Steven Feldman to Tuberculosis
This is a "connection" page, showing publications Steven Feldman has written about Tuberculosis.
Connection Strength
1.353
-
Chiriac A, Ferariu D, Solovan C, Brzezinski P, Feldman SR. Improvement in severe psoriasis associated with isoniazid treatment. Dermatol Online J. 2014 May 16; 20(5):22617.
Score: 0.473
-
Kaminska E, Patel I, Dabade TS, Chang J, Qureshi AA, O'Neill JL, Balkrishnan R, Feldman SR. Comparing the lifetime risks of TNF-alpha inhibitor use to common benchmarks of risk. J Dermatolog Treat. 2013 Apr; 24(2):101-6.
Score: 0.389
-
Sumner W, Feldman SR. Conversion to positive tuberculosis test during etanercept treatment of psoriasis. J Drugs Dermatol. 2007 Oct; 6(10):1048.
Score: 0.299
-
Nadkarni A, Hyde K, Cardwell LA, Feldman SR. Biologics monitoring: incongruity between recommendations and clinician monitoring trends. J Dermatolog Treat. 2020 Aug; 31(5):450-451.
Score: 0.175
-
Menter A, Feldman SR, Weinstein GD, Papp K, Evans R, Guzzo C, Li S, Dooley LT, Arnold C, Gottlieb AB. A randomized comparison of continuous vs. intermittent infliximab maintenance regimens over 1 year in the treatment of moderate-to-severe plaque psoriasis. J Am Acad Dermatol. 2007 Jan; 56(1):31.e1-15.
Score: 0.017